Seminars in Oncology
Volume 34, Issue 4 , Pages 321-326, August 2007

Adjuvant Therapy for Pancreas Cancer: Advances and Controversies

  • Mary F. Mulcahy

      Affiliations

    • Corresponding Author InformationAddress correspondence to Mary F. Mulcahy, MD, Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, 676 North Saint Clair, Suite 850, Chicago, IL 60611.

Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Research funding received from Lilly, Genetech, and Sanofi-Aventis.

PII: S0093-7754(07)00101-7

doi:10.1053/j.seminoncol.2007.05.006

Seminars in Oncology
Volume 34, Issue 4 , Pages 321-326, August 2007

Article Tools